肯尼亚和乌干达社区健康工作者协助的远程医疗用于中重度高血压管理:一项随机对照试验
在肯尼亚和乌干达农村地区开展试点随机对照试验,纳入200例血压≥160/100 mmHg的成年人,比较临床医生驱动、社区健康工作者协助的远程医疗与诊所随访。24周高血压控制率远程医疗组77% vs 诊所组51%(RD 26%,95%CI 14%-38%,p<0.001),48周分别为86% vs 44%(RD 42%,95%CI 30%-53%,p<0.001)。
要点
- 24周高血压控制率远程医疗组77% vs 诊所组51%(RD 26%,95%CI 14%-38%,p<0.001)。
- 48周高血压控制率远程医疗组86% vs 诊所组44%(RD 42%,95%CI 30%-53%,p<0.001)。
- 3例死亡(远程医疗组2例,诊所组1例),均与研究干预无关。
核心结论
- 在这项试点随机对照试验中,临床医生驱动、社区健康工作者协助的远程医疗管理高血压,与诊所随访相比改善了高血压控制并减少了重度高血压。
- 针对中重度高血压患者的远程医疗是改善心血管疾病最高风险人群结局的有前景的方法。
研究设计与样本
- 试点随机对照试验(RCT),在乌干达和肯尼亚农村地区开展,比较临床医生通过远程医疗提供高血压治疗(依从性评估、咨询、决策)并由社区健康工作者在 participant 家中协助,与诊所高血压随访(NCT04810650)。
- 通过社区健康工作者入户筛查招募≥40岁、血压≥160/100 mmHg的成年人,不限HIV状态;筛查2965名成年人,识别266名(9%)重度高血压患者,纳入200名(远程医疗组98例,诊所组102例)。
- 参与者67%为女性,中位年龄62岁(Q1-Q3 51-72);14%感染HIV。
- 随机分组未设盲,除研究统计师外;所有参与者均使用标准国家指南推荐的降压药物。
主要发现
- 第24周血压测量:干预组96/99例,对照组99/102例;第24周高血压控制率远程医疗组77% vs 诊所组51%(风险差26%,95%CI 14%-38%,p<0.001)。
- 第48周高血压控制率远程医疗组86% vs 诊所组44%(风险差42%,95%CI 30%-53%,p<0.001)。
- 3例参与者死亡(远程医疗组2例,诊所组1例);所有死亡均与研究干预无关。
临床怎么用
- 作者认为,针对中重度高血压患者的远程医疗是改善心血管疾病最高风险人群结局的有前景的方法。
- 原文未据此给出推荐。
局限性
- 研究受样本量小限制,尽管在两国三个初级卫生中心开展使结果得到加强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertension is underdiagnosed and undertreated in sub-Saharan Africa. Improving hypertension treatment within primary health centers can improve cardiovascular disease outcomes; however, individuals with moderate-severe hypertension face additional barriers to care, including the need for frequent clinic visits to titrate medications. We conducted a pilot study to test whether a clinician-driven, community health worker (CHW)-facilitated telehealth intervention would improve hypertension control among adults with severe hypertension in rural Uganda and Kenya. METHODS AND FINDINGS: We conducted a pilot randomized controlled trial (RCT) of hypertension treatment delivered via telehealth by a clinician (adherence assessment, counseling, decision-making) and facilitated by a CHW in the participant's home, compared to clinic-based hypertension care (NCT04810650). We recruited adults ≥40 years with BP ≥ 160/100 mmHg at household screening by CHWs, with no restrictions by HIV status. After initial evaluation at the clinic, participants were randomized to telehealth or clinic-based hypertension follow-up. Randomization assignment was not blinded, except for the study statistician. All participants were treated using standard country guideline-based antihypertensive drugs. The primary outcome was hypertension control at 24 weeks (BP < 140/90 mmHg). We also assessed hypertension control at 48 weeks. In intention-to-treat analyses, we compared outcomes between randomized arms with targeted minimum loss-based estimation using sample-splitting to select optimal adjustment covariates (candidates: age, sex, baseline hypertension severity, and country). We screened 2,965 adults ≥40 years, identifying 266 (9%) with severe hypertension and enrolling 200 (98 telehealth arms, 102 clinic arms). Participants were 67% women, median age of 62 years (Q1-Q3 51-72); 14% with HIV. Week 24 blood pressure was measured in 96/99 intervention and 99/102 control participants; week 24 hypertension control was 77% in telehealth and 51% in clinic arms (risk difference (RD) 26%, 95% confidence interval (CI) [14%, 38%], p < 0.001). Week 48 hypertension control was 86% in telehealth and 44% in clinic arms (RD 42%, 95% CI [30%, 53%], p < 0.001). Three participants died (telehealth: 2, clinic: 1); all deaths were unrelated to the study interventions. Our study was limited by its small sample size, although findings are strengthened by being conducted in three primary health centers across two countries. CONCLUSION: In this pilot, RCT, clinician-driven, CHW-facilitated telehealth for hypertension management improved hypertension control and reduced severe hypertension compared to clinic-based care. Telehealth focused on individuals with moderate-severe hypertension is a promising approach to improve outcomes among those with the highest risk for CVD.
引用
- Hickey MD, Owaraganise A, Ogachi S, et al. Community health worker-facilitated telehealth for moderate-severe hypertension care in Kenya and Uganda: A randomized controlled trial. PLoS Med. 2025. PMID: 40472026. doi:10.1371/journal.pmed.1004632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。